Laval, Canada

Anne-Marie Lanteigne

This inventor holds 1 USPTO granted patent, plus 4 CIPO patents. Top assignee: Glaxosmithkline Biologicals Sa. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anne-Marie Lanteigne. Retrieved from https://idiyas.com/inventor/anne-marie-lanteigne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2015

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Anne-Marie Lanteigne

Introduction

Anne-Marie Lanteigne is a notable inventor based in Laval, Canada. She has made significant contributions to the field of medicine through her innovative work. With a focus on immunogenic compositions, her research has the potential to impact healthcare positively.

Latest Patents

Anne-Marie holds one patent for an immunogenic composition. This invention relates to the use of an immunogenic or immunostimulatory composition comprising an outer membrane protein (OMP) and an LPS molecule in medicine. The methods for preparing this composition are also detailed in her patent, showcasing her expertise in the field.

Career Highlights

Anne-Marie is associated with GlaxoSmithKline Biologicals SA, a leading company in the pharmaceutical industry. Her work there emphasizes her commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout her career, Anne-Marie has collaborated with esteemed colleagues, including Normand Blais and Daniel Larocque. These partnerships highlight the collaborative nature of innovation in the scientific community.

Conclusion

Anne-Marie Lanteigne's contributions to immunogenic compositions reflect her dedication to advancing medical research. Her innovative work continues to inspire future developments in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…